Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- ChecktodayChange DetectedA new page revision tag v3.5.3 was added to update the version history, and the older revision tag v3.5.0 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded 'Small cell lung carcinoma' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource entry.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision on the page updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor platform update that does not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision history updated: added Revision v3.4.1 and removed Revision v3.4.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.